Augmentation of the inhibitory effect of FK480, a CCK-A receptor antagonist, on pancreatic exocrine secretion by achlorhydria

Pancreas

Volumn 17, Issue 1, 1998, Pages 57-64

  Kuno, Masako ^a   Sogabe, Hajime ^a   Ito, Harunobu ^a   Matsuo, Teruaki ^a   Satoh, Yoshinari ^a   Motoyama, Yukio ^a   Tanaka, Hirokazu ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Cholecystokinin receptor antagonist; Gastric acid secretion; Pancreatic exocrine secretion

Indexed keywords

1 [2,3 DIHYDRO 1 (2' METHYLPHENACYL) 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL] 3 (3 METHYLPHENYL)UREA; AMYLASE; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; FAMOTIDINE; N [1 (2 FLUOROPHENYL) 3,4,6,7 TETRAHYDRO 4 OXOPYRROLO[3,2,1 JK][1,4]BENZODIAZEPIN 3 YL] 1H INDOLE 2 CARBOXAMIDE;

ACHLORHYDRIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIGESTION; DOSE RESPONSE; DRUG MECHANISM; ENZYME RELEASE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PANCREAS JUICE; PANCREAS SECRETION; PRIORITY JOURNAL; RAT; STOMACH ACID SECRETION;

EID: 0031841199     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199807000-00007     Document Type: Article

References (21)

1. Tachibana I, Otsuki M. Effect of a new benzodiazepine derivative cholecystokinin pancreatic antagonist FK480 on pancreatic exocrine secretion in anesthesized rats. Dig Dis Sci 1994;39:1321-8.
2. Moriyoshi Y, Shiratori K, Takeuchi T, Watanabe S. Effect of a novel cholecystokinin receptor antagonist, FK480, administered intraduodenally, on pancreatic secretion in rats. Pancreas 1995;10: 295-300.
3. Ito H, Sogabe H, Nakarai T, et al. Pharmacological profile of FK480, a novel cholecystokinin type-A receptor antagonist: comparison to Loxiglumide. J Pharmacol Exp Ther 1994;268:571-5.
4. Lloyd KC, Raybould HE, Walsh JH. Cholecystokinin inhibits gastric acid secretion through type "A" cholecystokinin receptors and somatostatin in rats. Am J Physiol 1992;263:G287-92.
5. Burckhardt B, Delco F, Ensinck JW. Cholecystokinin as a physiological regulator of gastric acid secretion in man. Eur J Clin Invest 1994;24:370-6.
6. Singer MV. Pancreatic secretory response to intestinal stimulants; a review. Scand J Gastroenterol 1987;22(Suppl 139):1-13.
7. Ghosh MN, Schild HO. Continuous recording of gastric acid secretion in the rats. Br J Pharmacol Chemother 1958;13;54-61.
8. Satoh Y, Matsuo T, Sogabe H, et al. Studies on a novel, potent and orally effective cholecystokinin-A antagonist, FK480. Synthesis and structure-activity relationships of FK480 and related compounds. Chem Pharm Bull 1994;42:2071-83.
9. Nishida A, Akuzawa S, Kobayashi M, et al. Pharmacological profile of YM022, a potent and selective gastrin/cholecystokinin-B receptor antagonist. Jpn J Pharmacol 1993;Suppl 1:194P.
10. Ito H, Sogabe H, Satoh Y, CCK-A receptor antagonists [review article]. Drugs Fut 1995;20:587-99.
11. Macovec F. CCK-B/gastrin-receptor antagonists [review article]. Drugs Fut 1995;18:919-31.
12. Shiratori K, Shimizu K, Watanabe S, Takeuchi T, Moriyoshi Y. Effect of CCK antagonists CR1409 and CR1505 on rat pancreatic secretion in vivo. Pancreas 1989;4:744-50.
13. Liddle RA, Green GM, Conrad CK, Williams JA. Proteins but not amino acids, carbohydrates, or fats stimulate cholecystokinin secretion in the rat. Am J Physiol 1986;251:G243-8.
14. Bilski J, Konturek PK, Krzyzek E, et al. Feedback control of pancreatic secretion in rats. Role of gastric acid secretion. J Physiol Pharmacol 1992;43:237-57.
15. Konturek SJ, Bilski J, Cieszokowski M. Role of cholecystokinin in the intestinal fat- and acid-induced inhibition of gastric secretion. Regul Pept 1992;20:97-109.
16. Shiratori K, Watanabe S, Shimizu K, Moriyosi Y, Takeuchi T. Effect of a novel and potent CCK-B receptor antagonist, YM022, on gastric and pancreatic secretion in vivo in rats. Gastroenterology 1995;108(Suppl):A218.
17. Nishida A, Yuki H, Tsutsumi R, et al. YM022, a very potently and specifically inhibited acid secretion induced by deoxyglucose (2-DG)-induced gastric acid secretion in rats. Gastroenterology 1993;104(Suppl):A159.
18. Miyata K, Kamato T, Nisida A, Honda K. Studies on the mechanism for gastric mucosal protection by famotidine in rats. Jpn J Pharmacol 1991;55:211-22.
19. Mori K, Marugami Y, Suganuma M, et al. Inhibitory effect of omeprazole on caerulein-induced pancreatitis: comparison with the effect of nafamostat mesilate. J Jpn Pancr Soc 1995;10:345-50.
20. Arai Y, Nakamura T, Terada A, Suda T, Takebe K. An acidic change in the gastric and jejunal juice of chronic pancreatitis patients. J Jpn Pancre Soc 1996;19:223-30.
21. Bovo P, Cataudella G, Francesco VD, et al. Intraluminal gastric pH in chronic pancreatitis. Gut 1995;36:294-8.